October 2015 Archives by date

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...

Starting: Thu Oct 1 05:10:22 PDT 2015
Ending: Fri Oct 30 07:19:44 PDT 2015
Messages: 123

• [Ip-health] Reuters: Call for Britain to over-ride patents on Roche cancer drug   Thiru Balasubramaniam
• [Ip-health] Council of Europe calls on measures to encourage the pharmaceutical industry to respond more effectively to public health needs   Patrick Durisch
• [Ip-health] FiercePharma: U.K. patient group demands government override Roche's Kadcyla patents   Andrew S. Goldman
• [Ip-health] Pharmalot: U.K. patients want government to override Roche patent on cancer drug   Zack Struver
• [Ip-health] 7 House Members Push USTR to Support Indefinite Waiver on Pharm. Patent Rules for LDCs   Andrew S. Goldman
• [Ip-health] The release on the 7 House member LDC letter, with formatting fixed.   Jamie Love
• [Ip-health] FTC Files Amicus Brief Explaining that Pharmaceutical "Product Hopping" Can Violate the Antitrust Laws   Tahir Amin
• [Ip-health] Bloomberg on price increases for existing rx: Pfizer Raised Prices on 133 Drugs This Year, And It's Not Alone   Steven Knievel
• [Ip-health] Australian Financial Review: Australia and US battle over IP rights for top selling drugs   Thiru Balasubramaniam
• [Ip-health] IUST: TPP Ministerial May Be Extended Again As U.S., Australia Still At Odds On Biologics   Peter Maybarduk
• [Ip-health] IUST: U.S., Australia Move Toward Biologics Compromise With Options   Thiru Balasubramaniam
• [Ip-health] WaPo: Fierce split over next-generation drugs holds up Pacific Rim trade talks   Peter Maybarduk
• [Ip-health] Australian Financial Review: US, Australia drug dispute is holding up settlement of the Trans Pacific Trade Deal   Thiru Balasubramaniam
• [Ip-health] New York Times: As Pacific Trade Negotiators Haggle, U.S. Officials Remain Hopeful   Thiru Balasubramaniam
• [Ip-health] WIPO General Assembly 2015: Opening statement of India   Thiru Balasubramaniam
• [Ip-health] TPP live stream right now   Peter Maybarduk
• [Ip-health] Statement: TPP Meds Deal Would Still Cost Lives   Peter Maybarduk
• [Ip-health] Statement by MSF on the conclusion of TPP negotiations in Atlanta   Judit Rius
• [Ip-health] FT: And now the other TPP battles begin   Thiru Balasubramaniam
• [Ip-health] Statement of KEI on announcement that there is a consensus on the Trans Pacific Partnership (TPP) trade agreement   Zack Struver
• [Ip-health] Statement by MSF on the conclusion of TPP negotiations   Joanna Keenan
• [Ip-health] WIPO Assemblies to tackle several key unresolved issues   Mirza Alas
• [Ip-health] Suspension of UNODC work program on model law on fraudulent medicines   Mirza Alas
• [Ip-health] WIPO GA 2015: Statement by South Centre   Viviana Munoz
• [Ip-health] South Centre supports LDC TRIPS Art.66.1 extension   Viviana Munoz
• [Ip-health] The Vatican: Intellectual property rights must serve justice, common good   Elizabeth Rajasingh
• [Ip-health] NYT on TPP & meds IP   Peter Maybarduk
• [Ip-health] NZ official TPP Factsheet on Intellectual-Property   Jamie Love
• [Ip-health] Ip-health Digest, Vol 66, Issue 7   Jing Luo
• [Ip-health] Politico: Obama delivers TPP hard sell to pharma CEOs   Thiru Balasubramaniam
• [Ip-health] Blomberg: Indian Drugmakers Engineer Hep C Cocktails Impossible in West   Thiru Balasubramaniam
• [Ip-health] FDA enforcement discretion to allow unregistered generic Daraprim to be imported and sold at lower prices   Jamie Love
• [Ip-health] “No Human Right To Patent Protection,” Says UN Rapporteur On Cultural Rights   Elizabeth Rajasingh
• [Ip-health] WikiLeaks publishes final TPP IP chapter -- Contentious biologics clause revealed   Peter Maybarduk
• [Ip-health] FDA enforcement discretion to allow unregistered generic Daraprim to be imported and sold at lower prices   Biotech. Info. Inst.
• [Ip-health] Lessons from 20 years of TRIPS and public health   BAGOZZI, Daniela
• [Ip-health] WHO publication on trade and health now available   BAGOZZI, Daniela
• [Ip-health] Cato: TPP Ends Up with Pleasantly Mild Rules on Biologic Drug Monopolies   Peter Maybarduk
• [Ip-health] KEI Tweets on TPP IP Chapter   Elizabeth Rajasingh
• [Ip-health] UACT Statement on Trans-Pacific Partnership Agreement Negotiations   Claire Cassedy
• [Ip-health] TPP vs. May 10 Agreement   Peter Maybarduk
• [Ip-health] Wash Post: How Drug Price Controversy Could Sink TPP   Peter Maybarduk
• [Ip-health] US, AU and CA try to block WTO LDC drug patent waiver because PhRMA's not happy enough with the TPP   Thiru Balasubramaniam
• [Ip-health] LDCs be damned: USTR and Big Pharma seeks to eviscerate Least Developed Countries' insulation from pharmaceutical monopolies   Baker, Brook
• [Ip-health] Access to affordable medicines for world's poorest countries under threat: MSF   Joanna Keenan
• [Ip-health] TPP leak analysis   Peter Maybarduk
• [Ip-health] Fwd: TWN Info: WIPO - Disagreement over mandate renewal of work on genetic resources, traditional knowledge and folklore   K.M. Gopakumar
• [Ip-health] Don't Trade Our Lives Away: India’s National IPR Policy - Leaked Final Draft - Is it really the finest?   Zack Struver
• [Ip-health] WTO TRIPS Council (October 2015) to discuss LDC extension for pharmaceuticals, non-violation, review of the Paragraph 6 system   Thiru Balasubramaniam
• [Ip-health] Video: Coalition for Affordable T-DM1 Crown Use Request (in UK, for patents on cancer drug Kadcyla)   Thiru Balasubramaniam
• [Ip-health] NY Times: NY Attorney Gen. Examining Whether Turing Restricted Drug Access   Andrew S. Goldman
• [Ip-health] Four Reasons Drugs Are Expensive, Of Which Two Are False - Forbes   Claire Cassedy
• [Ip-health] Press release: HAI and MSF Report Shows European Commission’s Access to Medicines Commitments are ‘Empty Gestures’   Tessel Mellema
• [Ip-health] TWN Info: WIPO - Hectic negotiations to renew the mandate of IGC   Mirza Alas
• [Ip-health] Reminder - Geneva Event 15 October: Promoting quality medicines and saving lives   BAGOZZI, Daniela
• [Ip-health] Final draft, India National IPR Policy, by IP Think Tank constituted by DIPP, Ministry of Commerce and Industry   Zack Struver
• [Ip-health] Call for new membership: Communities Delegation to UNITAID   Wim vandevelde
• [Ip-health] Brief Video on Extension of TRIPS Exemptions for LDC's   Chase Perfect
• [Ip-health] Senator Sherrod Brown letter to USTR, supporting permanent waiver of WTO drug patent rules for LDCs | Knowledge Ecology International   Jamie Love
• [Ip-health] Pink Sheet article on the LDC drug patent waiver negotiation.   Jamie Love
• [Ip-health] Pink Sheet article on the LDC drug patent waiver negotiation.   Ellen 't Hoen
• [Ip-health] Some Links to commentary on the WTO negotiations over waiver of drug patents for Least Developed Countries (LDCs) | Knowledge Ecology International   Jamie Love
• [Ip-health] POLITICO PRO: Drug fight moves from TPP to WTO   Zack Struver
• [Ip-health] Reuters: Valeant subpoenaed by U.S. prosecutors; shares drop   Thiru Balasubramaniam
• [Ip-health] WIPO: IGC’s negotiation mandate renewed after intense negotiations   Mirza Alas
• [Ip-health] Froman's Choice   Jamie Love
• [Ip-health] TWN Info: US stands in the way of LDCs' pharmaceutical transition period   Sangeeta Shashikant
• [Ip-health] Live-Webcast: "Patent Sovereignty and International Law"   Oscar Andres Lizarazo Cortes
• [Ip-health] Greek drug firms’ rep warns parliament of Jewish conspiracy | The Times of Israel   Jamie Love
• [Ip-health] Contrast in privilege: US officials working to block WTO LDC drug patent waiver, and people affected by policy | Knowledge Ecology International   Jamie Love
• [Ip-health] WHO: Informal meeting to negotiate text on engagement with non-State actors   Mirza Alas
• [Ip-health] TWN Helath Info: WHO Secretariat “scare mongering” on FENSA   Mirza Alas
• [Ip-health] Infojustice Roundup - October 19, 2015   Michael Palmedo
• [Ip-health] Foreign Affairs: A Bitter Pill - Can the Access to Medicines Movement Score Another Victory?   Thiru Balasubramaniam
• [Ip-health] Letter from six NGOs to Obama on the WTO LDC patent waiver negotiation   Thiru Balasubramaniam
• [Ip-health] Inside U.S. Trade on WTO negotiations on LDC waiver for pharmaceutical products   Thiru Balasubramaniam
• [Ip-health] Clinton Has Evolved on Specialty Drug Policies   Claire Cassedy
• [Ip-health] The Hill: Pharma flap imperils president’s trade deal   Thiru Balasubramaniam
• [Ip-health] Infojustice Roundup - October 19, 2015   Meri Koivusalo
• [Ip-health] Reuters: States could be sanctioned for public health failings: WHO boss   Thiru Balasubramaniam
• [Ip-health] TWN Info: "Unconscionable and indefensible" U.S. 10-year offer to LDCs for pharmaceutical patent waiver   Sangeeta Shashikant
• [Ip-health] WHO Director-General addresses Inter-Parliamentary Union Assembly   Thiru Balasubramaniam
• [Ip-health] ​What's wrong with current system of funding R&D, and what are ideas for reforms?   Jamie Love
• [Ip-health] PLOS Blog: Drug pricing is out of control, what should be done?   Jamie Love
• [Ip-health] The scientists encouraging online piracy with a secret codeword   Elizabeth Rajasingh
• [Ip-health] BMJ: NICE approval of new hepatitis drug could result in £700m bill for NHS   Thiru Balasubramaniam
• [Ip-health] BMJ: Poor countries press for extension of exemption from drug patents   Thiru Balasubramaniam
• [Ip-health] Foreign Policy: The Age of Infection   Thiru Balasubramaniam
• [Ip-health] Inside U.S. Trade: Punke Rejects Continuing Doha After WTO Ministerial, Favors Plurilaterals   Thiru Balasubramaniam
• [Ip-health] Rep. Eshoo (D-CA) Sends Letter to USTR Requesting Clarification Regarding Conflicts in TPP Language on Damages and BPCIA, ISDS   Andrew S. Goldman
• [Ip-health] 29 October 2015 - WIPO Global Challenges Seminar on Advancing a New Generation of Products to Combat Neglected Tropical Diseases   Thiru Balasubramaniam
• [Ip-health] FDA warns of serious liver injury risk with hepatitis C treatments Viekira Pak and Technivie   Andrew S. Goldman
• [Ip-health] Drug with rage-inducing >5, 000% price-hike now has $1/pill competitor   Claire Cassedy
• [Ip-health] Drug with rage-inducing >5, 000% price-hike now has $1/pill competitor   ed.silverman at comcast.net
• [Ip-health] Press release: New study details safety and efficacy of re-treatment with Pyramax®   Elizabeth Poll
• [Ip-health] TWN Info: USTR Don't Gamble with Poor Peoples' Lives, NGO letter says   Sangeeta Shashikant
• [Ip-health] Dhaka Tribune: Six NGOs urge Obama to extend pharma transition period   Sangeeta Shashikant
• [Ip-health] Essential medicines are still essential   BAGOZZI, Daniela
• [Ip-health] Labor unions, NGOs: USTR Must End Secrecy Surrounding TTIP Negotiations   Jamie Love
• [Ip-health] Harvard's Oct. 23, 2015 forum on "Drug Pricing: Public Health Implications"   Zack Struver
• [Ip-health] Pharma Foxtrot or Citizen's Samba? towards a new biomedical R&D network.   Rachel Kiddell-Monroe
• [Ip-health] Inside U.S. Trade: Civil Society, AIDS Groups Decry U.S. Reluctance On TRIPS Drug Waiver   Zack Struver
• [Ip-health] Pharma Foxtrot or Citizen's Samba? towards a new biomedical R&D network.   Dean Baker
• [Ip-health] Updated Foreign Affairs article includes reference to LDC waiver: A Bitter Bill -Can the Access to Medicines Movement Score Another Victory?   Thiru Balasubramaniam
• [Ip-health] IP-Watch: After TTIP Round, “Important” Differences Remain On GIs, Negotiators Say   Thiru Balasubramaniam
• [Ip-health] Business Standard: US lambasts India on IPR, trade policies   Shailly Gupta
• [Ip-health] Fwd: Business Standard: US lambasts India on IPR, trade policies   Shailly Gupta
• [Ip-health] Business Standard- US decries India's economic policies ahead of Trade Policy Forum   Shailly Gupta
• [Ip-health] MSF webcast TONIGHT - The High Price of Medicine   Joanna Keenan
• [Ip-health] Fwd: MSF webcast TONIGHT - The High Price of Medicine   Joanna Keenan
• [Ip-health] The Wire: India Must Resist US Pressure on Generic Drugs, African Leaders to Tell Modi   Shailly Gupta
• [Ip-health] South Africa Should Override Patent on Key HIV Medicine After Widespread Stock Out Problem: MSF   Joanna Keenan
• [Ip-health] The Wire: India Must Resist US Pressure on Generic Drugs, African Leaders to Tell Modi   Baker, Brook
• [Ip-health] Dr. Margaret Chan's remarks at TRIPS at 20 symposium, 28 October 2015   Thiru Balasubramaniam
• [Ip-health] At African Union–India meeting in Delhi, African leaders and India should work together to protect access to affordable medicines   Shailly Gupta
• [Ip-health] WHO: Civil society protest over undermining of current negotiation on FENSA   Mirza Alas
• [Ip-health] Dr. Margaret Chan's remarks at TRIPS at 20 symposium, 28 October 2015   Mohga Kamal-Yanni
• [Ip-health] Dr. Margaret Chan's remarks at TRIPS at 20 symposium, 28 October 2015   George Carter
• [Ip-health] Dr. Margaret Chan's remarks at TRIPS at 20 symposium, 28 October 2015   Mohga Kamal-Yanni
• [Ip-health] CATO study of compulsory licensing & innovation   Peter Maybarduk
• [Ip-health] CATO study of compulsory licensing & innovation   Michael H Davis
• [Ip-health] ​Al Engleberg: How Government Policy Promotes High Drug Prices   Jamie Love
• [Ip-health] The long-arm of Article 3(5) of the proposed EU Trade Secrets Directive   Jamie Love

Last message date: Fri Oct 30 07:19:44 PDT 2015
Archived on: Fri Aug 28 11:58:53 PDT 2026

• Messages sorted by: [ thread ] [ subject ] [ author ]
• More info on this list...